A Study of TAK-500 With or Without Pembrolizumab in Adults With Select Locally Advanced or Metastatic Solid Tumors
Takeda
Takeda
Nuvation Bio Inc.
Tempus AI
Incyte Corporation
Actym Therapeutics, Inc.
Day One Biopharmaceuticals, Inc.
Pfizer
Elevation Oncology
Kymab Limited
Shanghai PerHum Therapeutics Co., Ltd.
Rain Oncology Inc
Novartis
Tango Therapeutics, Inc.
Pfizer
ADC Therapeutics S.A.
Medikine, Inc.
OHSU Knight Cancer Institute
Rutgers, The State University of New Jersey
pharmaand GmbH
Fate Therapeutics
Hoffmann-La Roche
Genmab
MacroGenics
Cambridge University Hospitals NHS Foundation Trust
Tocagen Inc.
CureOne
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Washington University School of Medicine
National Institutes of Health Clinical Center (CC)
Mayo Clinic
Cota Inc.
Western Regional Medical Center
Masonic Cancer Center, University of Minnesota
New York State Psychiatric Institute
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Case Comprehensive Cancer Center
Calando Pharmaceuticals
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Auron Healthcare GmbH
Millennium Pharmaceuticals, Inc.